United States Fidaxomicin Market Report 2018

March 2018 | 97 pages | ID: U1F94F01391QEN
QYResearch

Abstracts

In this report, the United States Fidaxomicin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Fidaxomicin in these regions, from 2013 to 2025 (forecast).

United States Fidaxomicin market competition by top manufacturers/players, with Fidaxomicin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astellas
• Merck

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Purity:90%
• Purity:95%
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Retail Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Fidaxomicin Market Report 2018

1 FIDAXOMICIN OVERVIEW

1.1 Product Overview and Scope of Fidaxomicin
1.2 Classification of Fidaxomicin by Product Category
  1.2.1 United States Fidaxomicin Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Fidaxomicin Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Purity:90%
  1.2.4 Purity:95%
  1.2.5 Others
1.3 United States Fidaxomicin Market by Application/End Users
  1.3.1 United States Fidaxomicin Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Retail Pharmacies
1.4 United States Fidaxomicin Market by Region
  1.4.1 United States Fidaxomicin Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Fidaxomicin Status and Prospect (2013-2025)
  1.4.3 Southwest Fidaxomicin Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Fidaxomicin Status and Prospect (2013-2025)
  1.4.5 New England Fidaxomicin Status and Prospect (2013-2025)
  1.4.6 The South Fidaxomicin Status and Prospect (2013-2025)
  1.4.7 The Midwest Fidaxomicin Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Fidaxomicin (2013-2025)
  1.5.1 United States Fidaxomicin Sales and Growth Rate (2013-2025)
  1.5.2 United States Fidaxomicin Revenue and Growth Rate (2013-2025)

2 UNITED STATES FIDAXOMICIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Fidaxomicin Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Fidaxomicin Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Fidaxomicin Average Price by Players/Suppliers (2013-2018)
2.4 United States Fidaxomicin Market Competitive Situation and Trends
  2.4.1 United States Fidaxomicin Market Concentration Rate
  2.4.2 United States Fidaxomicin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Fidaxomicin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES FIDAXOMICIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Fidaxomicin Sales and Market Share by Region (2013-2018)
3.2 United States Fidaxomicin Revenue and Market Share by Region (2013-2018)
3.3 United States Fidaxomicin Price by Region (2013-2018)

4 UNITED STATES FIDAXOMICIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Fidaxomicin Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Fidaxomicin Revenue and Market Share by Type (2013-2018)
4.3 United States Fidaxomicin Price by Type (2013-2018)
4.4 United States Fidaxomicin Sales Growth Rate by Type (2013-2018)

5 UNITED STATES FIDAXOMICIN SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Fidaxomicin Sales and Market Share by Application (2013-2018)
5.2 United States Fidaxomicin Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES FIDAXOMICIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Astellas
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Fidaxomicin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Fidaxomicin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Fidaxomicin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Fidaxomicin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview

7 FIDAXOMICIN MANUFACTURING COST ANALYSIS

7.1 Fidaxomicin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Fidaxomicin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Fidaxomicin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Fidaxomicin Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES FIDAXOMICIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Fidaxomicin Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Fidaxomicin Sales Volume Forecast by Type (2018-2025)
11.3 United States Fidaxomicin Sales Volume Forecast by Application (2018-2025)
11.4 United States Fidaxomicin Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Fidaxomicin
Figure United States Fidaxomicin Market Size (K Tablets) by Type (2013-2025)
Figure United States Fidaxomicin Sales Volume Market Share by Type (Product Category) in 2017
Figure Purity:90% Product Picture
Figure Purity:95% Product Picture
Figure Others Product Picture
Figure United States Fidaxomicin Market Size (K Tablets) by Application (2013-2025)
Figure United States Sales Market Share of Fidaxomicin by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure United States Fidaxomicin Market Size (Million USD) by Region (2013-2025)
Figure The West Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2025)
Figure United States Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Fidaxomicin Market Major Players Product Sales Volume (K Tablets) (2013-2018)
Table United States Fidaxomicin Sales (K Tablets) of Key Players/Suppliers (2013-2018)
Table United States Fidaxomicin Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Fidaxomicin Sales Share by Players/Suppliers
Figure 2017 United States Fidaxomicin Sales Share by Players/Suppliers
Figure United States Fidaxomicin Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Fidaxomicin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Fidaxomicin Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Fidaxomicin Revenue Share by Players/Suppliers
Figure 2017 United States Fidaxomicin Revenue Share by Players/Suppliers
Table United States Market Fidaxomicin Average Price (USD/ Tablets) of Key Players/Suppliers (2013-2018)
Figure United States Market Fidaxomicin Average Price (USD/ Tablets) of Key Players/Suppliers in 2017
Figure United States Fidaxomicin Market Share of Top 3 Players/Suppliers
Figure United States Fidaxomicin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Fidaxomicin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Fidaxomicin Product Category
Table United States Fidaxomicin Sales (K Tablets) by Region (2013-2018)
Table United States Fidaxomicin Sales Share by Region (2013-2018)
Figure United States Fidaxomicin Sales Share by Region (2013-2018)
Figure United States Fidaxomicin Sales Market Share by Region in 2017
Table United States Fidaxomicin Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Fidaxomicin Revenue Share by Region (2013-2018)
Figure United States Fidaxomicin Revenue Market Share by Region (2013-2018)
Figure United States Fidaxomicin Revenue Market Share by Region in 2017
Table United States Fidaxomicin Price (USD/ Tablets) by Region (2013-2018)
Table United States Fidaxomicin Sales (K Tablets) by Type (2013-2018)
Table United States Fidaxomicin Sales Share by Type (2013-2018)
Figure United States Fidaxomicin Sales Share by Type (2013-2018)
Figure United States Fidaxomicin Sales Market Share by Type in 2017
Table United States Fidaxomicin Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Fidaxomicin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Fidaxomicin by Type (2013-2018)
Figure Revenue Market Share of Fidaxomicin by Type in 2017
Table United States Fidaxomicin Price (USD/ Tablets) by Types (2013-2018)
Figure United States Fidaxomicin Sales Growth Rate by Type (2013-2018)
Table United States Fidaxomicin Sales (K Tablets) by Application (2013-2018)
Table United States Fidaxomicin Sales Market Share by Application (2013-2018)
Figure United States Fidaxomicin Sales Market Share by Application (2013-2018)
Figure United States Fidaxomicin Sales Market Share by Application in 2017
Table United States Fidaxomicin Sales Growth Rate by Application (2013-2018)
Figure United States Fidaxomicin Sales Growth Rate by Application (2013-2018)
Table Astellas Basic Information List
Table Astellas Fidaxomicin Sales (K Tablets), Revenue (Million USD), Price (USD/ Tablets) and Gross Margin (2013-2018)
Figure Astellas Fidaxomicin Sales Growth Rate (2013-2018)
Figure Astellas Fidaxomicin Sales Market Share in United States (2013-2018)
Figure Astellas Fidaxomicin Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Fidaxomicin Sales (K Tablets), Revenue (Million USD), Price (USD/ Tablets) and Gross Margin (2013-2018)
Figure Merck Fidaxomicin Sales Growth Rate (2013-2018)
Figure Merck Fidaxomicin Sales Market Share in United States (2013-2018)
Figure Merck Fidaxomicin Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fidaxomicin
Figure Manufacturing Process Analysis of Fidaxomicin
Figure Fidaxomicin Industrial Chain Analysis
Table Raw Materials Sources of Fidaxomicin Major Players/Suppliers in 2017
Table Major Buyers of Fidaxomicin
Table Distributors/Traders List
Figure United States Fidaxomicin Sales Volume (K Tablets) and Growth Rate Forecast (2018-2025)
Figure United States Fidaxomicin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Fidaxomicin Price (USD/ Tablets) Trend Forecast (2018-2025)
Table United States Fidaxomicin Sales Volume (K Tablets) Forecast by Type (2018-2025)
Figure United States Fidaxomicin Sales Volume (K Tablets) Forecast by Type (2018-2025)
Figure United States Fidaxomicin Sales Volume (K Tablets) Forecast by Type in 2025
Table United States Fidaxomicin Sales Volume (K Tablets) Forecast by Application (2018-2025)
Figure United States Fidaxomicin Sales Volume (K Tablets) Forecast by Application (2018-2025)
Figure United States Fidaxomicin Sales Volume (K Tablets) Forecast by Application in 2025
Table United States Fidaxomicin Sales Volume (K Tablets) Forecast by Region (2018-2025)
Table United States Fidaxomicin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Fidaxomicin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Fidaxomicin Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources